Getting Started with NGS for Oncology

Contact a representative



 

Next-Generation Sequencing (NGS).  Advancing Precision Oncology.

While it began as a revolutionary research tool a decade ago, NGS is now the method of choice for simultaneous genomic profiling of multiple cancer markers.  For hospitals, the advantages of NGS over traditional methods are indisputable in terms of time savings, tissue perservation, and a precision oncology approach to patient care. 




NGS In-House Advantages

With NGS testing in-house, you no longer have to give up your samples and rely on outside labs, which can take weeks and potentially lead to high failure rates.  With your sample and testing expertise onsite, your multidisciplinary team is always empowered with the information they need to tailor patient treatments for better outcomes.  

In-House NGS Testing



Hear how hospital care teams are using in-house NGS to improve patient care coordination and outcomes. 



NGS in Community Hospitals


image

Learn how community hospitals are benefiting from in-house NGS in an article from Luca Quagliata, PhD, Thermo Fisher Global Head of Medical Affairs.

 

Get your own NGS guide to find out:                                                        

  • Why NGS is such a transformative technology for precision oncology
  • How NGS helps improve patient outcomes
  • What the key oncology applications are, and the pros and cons of different sequencing methods
  • How surprisingly easy NGS is to implement and operate with its straight-forward, streamlined, highly automated workflow

 


image




Complete the form to download the guide.
 



A Simple Workflow for Any Lab

Now any hospital pathology lab can perform NGS. A highly automated workflow makes it easy for you to get started with your existing staff and infrastructure.  Intuitive reporting enables you to deliver the results that capture critical information about potential therapies, medical guidelines, and ongoing clinical trials.

Celiac & GRD

NGS tailored to your hospital - Today and tomorrow

As your hospital's needs evolve, your flexible NGS platform easily adapts to meet new demands for different types of assays.  

One Platform.  Multiple Applications.

  • Solid tumor profiling from FFPE tissue
  • Liquid biopsies
  • Hematological malignancy profiling
  • Tumor Mutational Burden (TMB) Analysis

 

Learn about Oncomine NGS solutions




Getting Started.  It's easier than you think.

While the idea of adopting NGS may seem overwhelming, we're confident that you'll find the NGS implementation process much easier than you might think.  Our NGS consultants are there every step of the way - from providing analytical assay validation services to creating a CLIA validated offering.  You'll be NGS proficient and efficient before you know it.  

 

Life lab flyer   Assay validation flyer



Endeavor to Leave No Patient Behind:  NGS Non-Small Cell Lung (NSCL) Biomarker Testing



In this CAP Today webinar, you'll learn how to keep pace with the fast-changing guidelines in precision oncology, test the most challenging samples, and optimize outcomes for as many NSCLC patients as possible. 



NGS in NSCLC:  Comprehensive Biomarker Testing



See how University Hospital Basel is using NGS testing to inform treatment decisions for lung cancer patients.

Subscribe here to stay abreast of the latest news about NGS in precision oncology.



Have questions?  We look forward to speaking with you about bringing NGS to your hospital's lab.